Lab
Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation was paid $1.09M by Medicaid between Jan 2021 and Nov 2024, across 2 billing codes. Its largest line is 81479, Unlisted molecular pathology procedure — 88% of everything it billed.
33Billing provider infoADAPTIVE BIOTECHNOLOGIES CORPORATION
SEATTLE, WA 98109
SEATTLE, WA 98109
33aNPI1508105024assigned 02/04/2013
33bProvider typeClinical Medical Laboratory
28Total paid$1.09M
24GClaims6,120
24DCodes billed2
24AFirst – last monthJan 2021 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Washington
Rank by total paid#21 of 76
Median peer was paid$90K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 318 | $122K | |
| 2022 | 1,042 | $171K | |
| 2023 | 2,177 | $305K | |
| 2024incomplete | 2,583 | $490K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81479 | Unlisted molecular pathology procedure | 88% | 5,544 | 4,156 | $958K |
| 0364U | 12% | 576 | 502 | $130K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBINS, CHAD (CEO, PRESIDENT, CO-FOUNDER)